UBS Group »

Newamsterdam Pharma Co Nv shares owned by UBS Group

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.9k 800 11.17
2023-06-30 $2.2k 183 11.89

More positions owned by UBS Group

Microsoft Corporation (MSFT)
Apple Call Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
NVIDIA Corporation (NVDA)
Ubs Group SHS (UBS)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Union Pacific Corporation (UNP)
Alphabet Cap Stk Cl C Put Option (GOOG)
Meta Platforms Cl A (META)

View all positions for UBS Group

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
Fcpm Iii Services B.v.
Viking Global Investors
RA Capital Management
Medicxi Ventures Management
BVF
Goldman Sachs Group
GMT Capital Corp
Millennium Management
Alyeska Investment Group
Opaleye Management
Schonfeld Strategic Advisors
Marshall Wace
Yarbrough Capital
HealthInvest Partners AB

View all funds holding Newamsterdam Pharma Co Nv